ATE377022T1 - Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung - Google Patents

Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung

Info

Publication number
ATE377022T1
ATE377022T1 AT98930433T AT98930433T ATE377022T1 AT E377022 T1 ATE377022 T1 AT E377022T1 AT 98930433 T AT98930433 T AT 98930433T AT 98930433 T AT98930433 T AT 98930433T AT E377022 T1 ATE377022 T1 AT E377022T1
Authority
AT
Austria
Prior art keywords
decapeptides
bind
isolated
hla molecules
hla
Prior art date
Application number
AT98930433T
Other languages
English (en)
Inventor
Danila Valmori
Jean-Charles Cerottini
Pedro Romero
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/880,963 external-priority patent/US6025470A/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE377022T1 publication Critical patent/ATE377022T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98930433T 1997-06-23 1998-06-18 Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung ATE377022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/880,963 US6025470A (en) 1997-06-23 1997-06-23 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
US09/061,388 US6277956B1 (en) 1997-06-23 1998-04-16 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

Publications (1)

Publication Number Publication Date
ATE377022T1 true ATE377022T1 (de) 2007-11-15

Family

ID=26741014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930433T ATE377022T1 (de) 1997-06-23 1998-06-18 Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung

Country Status (8)

Country Link
US (3) US6326200B1 (de)
EP (1) EP1012173B1 (de)
CN (1) CN1313481C (de)
AT (1) ATE377022T1 (de)
AU (1) AU732468B2 (de)
CA (1) CA2295321C (de)
NZ (1) NZ501752A (de)
WO (1) WO1998058951A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE377022T1 (de) * 1997-06-23 2007-11-15 Ludwig Inst Cancer Res Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
WO2001016320A1 (en) * 1999-08-30 2001-03-08 Ludwig Institute For Cancer Research Isolated nona and decapeptides which bind to hla molecules, and the use thereof
CA2388337C (en) 1999-10-22 2013-01-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
WO2001053833A1 (en) * 2000-01-20 2001-07-26 Ludwig Institute For Cancer Research Mage antigenic peptides which bind hla-b35 and hla-b44
FR2806727A1 (fr) * 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
CA2492823A1 (en) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
DE60234375D1 (de) * 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
BR0311995A (pt) * 2002-06-20 2005-04-05 Cytos Biotechnology Ag Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
AU2003283963A1 (en) 2002-09-27 2004-04-19 Ludwig Institute For Cancer Research Mage-c2 antigenic peptides and uses thereof
AU2004224761A1 (en) 2003-03-26 2004-10-07 Cytos Biotechnology Ag HIV-peptide-carrier-conjugates
US20060210588A1 (en) * 2003-03-26 2006-09-21 Cytos Biotechnology Ag Hiv-peptide-carrier-conjugates
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ES2373055T3 (es) * 2005-08-09 2012-01-31 Oncotherapy Science, Inc. Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno.
CA2636139A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
US8541559B2 (en) 2006-06-12 2013-09-24 Cytos Biotechnology Ag Process for producing aggregated oligonucleotides
WO2018094570A1 (zh) * 2016-11-22 2018-05-31 深圳华大基因研究院 多肽及其应用
WO2018094569A1 (zh) * 2016-11-22 2018-05-31 深圳华大基因研究院 多肽及其应用
CN110167956B (zh) * 2016-11-30 2023-04-07 深圳华大生命科学研究院 多肽及其应用
CN121443628A (zh) * 2023-04-14 2026-01-30 约翰斯·霍普金斯大学 异质新表位疫苗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US5487974A (en) * 1992-12-22 1996-01-30 Ludwig Institute For Cancer-Research Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells
US5554724A (en) 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
US5851523A (en) * 1994-03-24 1998-12-22 Ludwig Institute For Cancer Research. Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
US5554506A (en) 1994-03-24 1996-09-10 Ludwig Institute For Cancer Research Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
EP0756604A1 (de) * 1994-04-22 1997-02-05 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Melanoma antigene
US5874560A (en) * 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
JP4108126B2 (ja) * 1996-04-26 2008-06-25 リュクスウニヴェルシテート テ レイデン Ｔ細胞ペプチド・エピトープの選択と産生方法および選択したエピトープを組込むワクチン
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
ATE377022T1 (de) * 1997-06-23 2007-11-15 Ludwig Inst Cancer Res Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
US6025470A (en) * 1997-06-23 2000-02-15 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

Also Published As

Publication number Publication date
CA2295321A1 (en) 1998-12-30
US7344879B2 (en) 2008-03-18
CN1261374A (zh) 2000-07-26
US20030082804A1 (en) 2003-05-01
AU732468B2 (en) 2001-04-26
WO1998058951A1 (en) 1998-12-30
CN1313481C (zh) 2007-05-02
US7713714B2 (en) 2010-05-11
EP1012173A1 (de) 2000-06-28
EP1012173B1 (de) 2007-10-31
EP1012173A4 (de) 2000-07-05
CA2295321C (en) 2008-01-29
US6326200B1 (en) 2001-12-04
HK1028615A1 (en) 2001-02-23
AU7982798A (en) 1999-01-04
NZ501752A (en) 2000-12-22
US20040152193A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
ATE377022T1 (de) Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ATE318845T1 (de) Therapeutische multispezifische verbindungen, die antikörper gegen den fcalpha-rezeptor enthalten
AU694055B2 (en) Method of using dynamic database to improve telephone number portability
NO975387D0 (no) Fremgangsmåte for fremstilling av 3-haloalkyl-1H-pyrazoler
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
NO20001583D0 (no) Stimulering av hematopoetiske celler in vitro
TR199701574T2 (xx) �midazol bile�imleri
BR9602786A (pt) Método para produzir oxigênio e gerar potência
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
ES2161279T3 (es) Nucleosidos y nucleotidos que contienen racimos de boro.
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
NO975557D0 (no) Immortalisering og dismortalisering av celler
BG103832A (en) Leptin as tumour cells proliferation inhibitor
TR199801328T2 (xx) Yeni tarz benzoilguanidin-t�revleri, �retim y�ntemleri.
DE69736832D1 (de) Passiv verabreichter antikörper, der die futterausnutzung erhöht
DK1025083T3 (da) Fremgangsmåde til stereoselektiv syntese af prostacyclin-derivater
DE69838646D1 (de) Isolierte decapeptide, die an hla moleküle binden, sowie deren verwendung
DE60007120D1 (de) Isophosphoramide-senfgasanalogen und deren verwendung
BG100248A (bg) Инхибитори на скваленсинтетаза
ATE265861T1 (de) Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
DE69428909D1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
ES2187727T3 (es) Medicamentos y cosmeticos que comprenden extractos de zizyphus spina-christi.
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties